TCL Archive NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted. June 20, 2003
TCL Archive Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions August 16, 1991
TCL Archive NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments March 22, 1985
TCL Archive In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct. June 6, 1975
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products June 3, 2011
